Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myeloid cell surface proteins are a diverse group of proteins expressed on the surface of cells derived from the myeloid lineage (monocytes, macrophages, dendritic cells, granulocytes, megakaryocytes, and erythrocytes). These proteins serve as markers for identifying myeloid cell subtypes and play critical roles in immune response regulation, cell signaling, migration, and interaction with other immune cells. They are important in sensing infection or tissue injury, regulating recruitment and differentiation, mediating phagocytosis, and modulating inflammation. These proteins are used as diagnostic/prognostic biomarkers in hematological malignancies and as therapeutic targets.
Varies depending on the specific protein. Examples include: Antibody-mediated cytotoxicity, receptor blockade, signal modulation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myeloid Cell Surface Protein.